{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T12:34:25Z","timestamp":1793709265208,"version":"4.6.1"},"update-to":[{"DOI":"10.12688\/f1000research.134171.1","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T00:00:00Z","timestamp":1727308800000}}],"reference-count":48,"publisher":"F1000 Research Ltd","license":[{"start":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T00:00:00Z","timestamp":1727308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["f1000research.com"],"crossmark-restriction":false},"short-container-title":["F1000Res"],"abstract":"<ns3:p>\n                    <ns3:bold>Introduction:<\/ns3:bold>\n                    The COVID-19 virus has impacted people worldwide, causing significant changes in their lifestyles. Since the emergence of the epidemic, attempts have begun to prepare a vaccine that can eliminate the virus and restore balance to life in the entire world. Over the past two years, countries and specialized companies have competed to obtain a license from the World Health Organization for the vaccines that were discovered. After the appearance of vaccines in the health community, comparisons and fears of their side effects began, but people don\u2019t get an answer to the question of which is the best vaccine.\n                    <ns3:bold>Methods:<\/ns3:bold>\n                    IEEE Xplore, ScienceDirect, the New England Journal of Medicine, Google Scholar, and PubMed databases were searched for literature on the COVID-19 vaccine and its side effects. we surveyed the literature on the COVID-19 vaccine\u2019s side effects and the sorts of side effects observed after vaccination. Depending on data from the literature, we compared these vaccines in terms of side effects, then we analyzed the gaps and obstacles of previous studies and made proposals to process these gaps in future studies.\n                    <ns3:bold>Results:<\/ns3:bold>\n                    Overall, 17 studies were included in this scoping systematic review as they fulfilled the criteria specified, the majority of which were cross-sectional and retrospective cross-sectional studies. Most of the side effects were mild, self-limiting, and common. Thus, they usually resolve within 1\u20133 days after vaccination. Factors associated with higher side effects included advanced age, allergic conditions, those taking other medications (particularly immunosuppressive ones), those with a history of type II diabetes, heart disease, hypertension, COVID-19 infection, and female sex. Our meta\u2010analyses also found that mRNA vaccines looked to be more effective, while inactivated vaccinations had fewer side effects.\n                    <ns3:bold>Conclusion:<\/ns3:bold>\n                    This review shows that the COVID-19 vaccine is safe to administer and induces protection.\n                  <\/ns3:p>","DOI":"10.12688\/f1000research.134171.2","type":"journal-article","created":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T06:25:10Z","timestamp":1727331910000},"page":"604","update-policy":"https:\/\/doi.org\/10.12688\/f1000research.crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["COVID-19 vaccinations and their side effects: a scoping systematic review"],"prefix":"10.12688","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9923-4979","authenticated-orcid":false,"given":"Hind","family":"Monadhel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9797-421X","authenticated-orcid":false,"given":"Ayad","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athraa","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2560","published-online":{"date-parts":[[2024,9,26]]},"reference":[{"key":"ref27","doi-asserted-by":"publisher","first-page":"134-140","DOI":"10.48161\/qaj.v1n2a59","article-title":"COVID-19 World Vaccine Adverse Reactions Based on Machine Learning Clustering Algorithm.","volume":"1","author":"L Abdulrahman","year":"2021","journal-title":"Qubahan Academic J."},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1101\/2021.04.16.21255618","article-title":"Adverse effects of COVID-19 vaccination: machine learning and statistical approach to identify and classify incidences of morbidity and post-vaccination reactogenicity.","author":"M Ahamad","year":"2020","journal-title":"medRxiv."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"6588-6594","DOI":"10.1002\/jmv.27124","article-title":"Safety of COVID-19 vaccines.","volume":"93","author":"Q Al Khames Aga","year":"2021","journal-title":"J. Med. Virol."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.3390\/vaccines9111297","article-title":"Side Effects of COVID-19 Pfizer-BioNTech mRNA Vaccine in Children Aged 12\u201318 Years in Saudi Arabia.","volume":"9","author":"E Alamer","year":"2021","journal-title":"Vaccines."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"674","DOI":"10.3390\/vaccines9060674","article-title":"Evaluation of Side Effects Associated with COVID-19 Vaccines in Saudi Arabia.","volume":"9","author":"A Alhazmi","year":"2021","journal-title":"Vaccines."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"102207","DOI":"10.1016\/j.dsx.2021.102207","article-title":"Potential adverse effects of COVID19 vaccines among Iraqi population; a comparison between the three available vaccines in Iraq; a retrospective cross-sectional study.","volume":"15","author":"H Almufty","year":"2021","journal-title":"Diabetes Metab. Syndr."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"4418-4421","DOI":"10.26355\/eurrev_202106_26153","article-title":"Side effects after COVID-19 vaccinations among residents of Poland.","volume":"25","author":"S Andrzejczak-Grz\u0105dko","year":"2021","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref52","article-title":"European Medicines Agency.","year":"cited 2023 Jan 21"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"4077-4083","DOI":"10.2147\/IDR.S332354","article-title":"Adverse Effects of the COVID-19 Vaccine Reported by Lecturers and Staff of Kabul University of Medical Sciences, Kabul, Afghanistan.","volume":"14","author":"M Azimi","year":"2021 Oct 4 cited 2022 Apr 15","journal-title":"Infect. Drug Resist."},{"key":"ref53","article-title":"Bharat Biotech.","year":"cited 2023 Jan 21"},{"key":"ref15","article-title":"Understanding mRNA COVID-19 vaccines.","year":"2021a cited 2023 Jan 20"},{"key":"ref18","article-title":"Understanding viral vector COVID-19 vaccines.","year":"2021b cited 2023 Jan 22"},{"key":"ref24","article-title":"Medical News Today.","year":"cited 2023 Jan 23"},{"key":"ref23","article-title":"World Health Organization.","year":"cited 2023 Jan 22"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"5338","DOI":"10.3390\/jcm10225338","article-title":"Self-Reported Adverse Events of COVID-19 Vaccines in Polish Healthcare Workers and Medical Students. Cross-Sectional Study and Pooled Analysis of CoVaST Project Results in Central Europe.","volume":"10","author":"A Dziedzic","year":"2021","journal-title":"J. Clin. Med."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1389-1401","DOI":"10.2147\/IJGM.S310497","article-title":"Minor to Moderate Side Effects of Pfizer-BioNTech COVID-19 Vaccine Among Saudi Residents: A Retrospective Cross-Sectional Study.","volume":"14","author":"N El-Shitany","year":"2021","journal-title":"Int. J. Gen. Med."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"442-456","DOI":"10.3390\/immuno1040032","article-title":"Immunological mechanisms of vaccine-induced protection against SARS-CoV-2 in humans.","volume":"1","author":"K Goyal","year":"2021","journal-title":"Immuno."},{"key":"ref30","article-title":"Metrics for Multi-Class Classification: An Overview. arXiv:2008.05756v1 [stat.ML].","author":"M Grandini","year":"August 13, 2020"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"556","DOI":"10.3390\/vaccines9060556","article-title":"Side Effects and Perceptions Following COVID-19 Vaccination in Jordan: A Randomized, Cross-Sectional Study Implementing Machine Learning for Predicting Severity of Side Effects.","volume":"9","author":"M Hatmal","year":"2021","journal-title":"Vaccines."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1007\/s10916-019-1445-8","article-title":"A systematic review for enabling of develop a blockchain technology in healthcare application: Taxonomy, substantially analysis, motivations, challenges, recommendations and future direction.","volume":"43","author":"M Hussien","year":"2019","journal-title":"J. Med. Syst."},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1101\/2021.02.08.21251366","article-title":"Survey of symptoms following COVID-19 vaccination in India.","author":"R Jayadevan","year":"2021","journal-title":"medRxiv."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"4420-4429","DOI":"10.1002\/jmv.26996","article-title":"Non-life-threatening adverse effects with COVID-19 mRNA-1273 vaccine: A randomized, cross-sectional study on healthcare workers with detailed self-reported symptoms.","volume":"93","author":"R Kadali","year":"2021","journal-title":"J. Med. Virol."},{"key":"ref55","doi-asserted-by":"publisher","first-page":"526-544","DOI":"10.4168\/aair.2021.13.4.526","article-title":"COVID-19 vaccine-associated anaphylaxis and allergic reactions: consensus statements of the KAAACI Urticaria\/Angioedema\/Anaphylaxis Working Group.","volume":"13","author":"M Kim","year":"2021","journal-title":"Allergy Asthma Immunol. Res."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"576-581","DOI":"10.1016\/j.jiac.2021.12.034","article-title":"Adverse reactions to the BNT162b2 and mRNA-1273 mRNA COVID-19 vaccines in Japan.","volume":"28","author":"H Kitagawa","year":"2022","journal-title":"J. Infect. Chemother."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"752","DOI":"10.3390\/biology10080752","article-title":"Side Effects of mRNA- Based and Viral Vector-Based COVID-19 Vaccines among German Healthcare Workers.","volume":"10","author":"M Klugar","year":"2021","journal-title":"Biology."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"29-48","DOI":"10.20506\/rst.26.1.1724","article-title":"A brief history of vaccines and vaccination.","volume":"26","author":"M Lombard","year":"2007","journal-title":"Revue Scientifique et Technique-Office International des Epizooties."},{"key":"ref1","doi-asserted-by":"publisher","first-page":"e7423","DOI":"10.7759\/cureus.7423","article-title":"Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): An Update.","volume":"12","author":"P Mahendra","year":"2020","journal-title":"Cureus."},{"key":"ref50","article-title":"US Food and Drug Administration.","year":"cited 2023 Jan 22"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.","volume":"6","author":"D Moher","year":"2009","journal-title":"PLoS Med."},{"key":"ref20","article-title":"Vaccine types.","year":"2021 cited 2023 Jan 22"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"1546-1550","DOI":"10.1001\/archinte.1996.00440130090009","article-title":"Side effects associated with influenza vaccination in healthy working adults: a randomized, placebo-controlled trial.","volume":"156","author":"K Nichol","year":"1996","journal-title":"Arch. Intern. Med."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"707-708","DOI":"10.1001\/jama.2020.0757","article-title":"Coronavirus infections-more than just the common cold.","volume":"323","author":"C Paules","year":"2020","journal-title":"JAMA."},{"key":"ref49","article-title":"US Food and Drug Administration.","year":"cited 2023 Jan 22"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"S5-S11","DOI":"10.1038\/nm1209","article-title":"Vaccines: past, present and future.","volume":"11","author":"S Plotkin","year":"2005","journal-title":"Nat. Med."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.3390\/jcm10071428","article-title":"Prevalence of COVID-19 Vaccine Side Effects among Healthcare Workers in the Czech Republic.","volume":"10","author":"A Riad","year":"2021","journal-title":"J. Clin. Med."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"219-226","DOI":"10.1016\/j.ijid.2021.08.013","article-title":"Side effects and perceptions following Sinopharm COVID-19 vaccination.","volume":"111","author":"B Saeed","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1-7","DOI":"10.14744\/ejmo","article-title":"2019 novel coronaviruses (COVID-19) outbreak: a review of the current literature.","volume":"4","author":"A Sahin","year":"2020","journal-title":"Eur. J. Med. Oncol."},{"key":"ref48","article-title":"World Health Organization.","year":"cited 2023 Jan 22"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"108086","DOI":"10.1016\/j.intimp.2021.108086","article-title":"Vaccine design and delivery approaches for COVID-19.","volume":"100","author":"K Shahzamani","year":"2021 Jul","journal-title":"Int. Immunopharmacol."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"106054","DOI":"10.1016\/j.ijantimicag","article-title":"severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies.","volume":"56","author":"A Sharma","year":"2020","journal-title":"Int. J. Antimicrob. Agents."},{"key":"ref51","article-title":"Food and Drug Administration Philippines.","year":"cited 2023 Jan 22"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"100124","DOI":"10.1016\/j.metop.2021.100124","article-title":"COVID-19 vaccines: Current evidence and considerations.","volume":"12","author":"A Tavilani","year":"2021","journal-title":"Metab Open."},{"key":"ref22","article-title":"VIEW-HUB.","year":"cited 2023 Jan 23"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"e21-e29","DOI":"10.1016\/S2468-2667(20)30269-3","article-title":"Detecting COVID-19 infection hotspots in England using large-scale self-reported data from a mobile application: a prospective, observational study.","volume":"6","author":"T Varsavsky","year":"2021","journal-title":"Lancet Public Health."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"635-664","DOI":"10.1128\/MMBR.69.4.635-664.2005","article-title":"Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus.","volume":"69","author":"S Weiss","year":"2005","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"ref17","article-title":"How do vector vaccines work?","year":"2021a cited 2023 Jan 20"},{"key":"ref59","article-title":"WHO COVID-19 dashboard - WHO data.","year":"2024"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9111369","article-title":"Unfolding the Mild to Moderate Short-Term Side Effects of Four COVID-19 Vaccines Used in Bahrain: A Cross-Sectional Study.","volume":"9","author":"M Zahid","year":"2021","journal-title":"Vaccines (Basel)."}],"container-title":["F1000Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/f1000research.com\/articles\/12-604\/v2\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/12-604\/v2\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/12-604\/v2\/iparadigms","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T07:40:12Z","timestamp":1730878812000},"score":1,"resource":{"primary":{"URL":"https:\/\/f1000research.com\/articles\/12-604\/v2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,26]]},"references-count":48,"URL":"https:\/\/doi.org\/10.12688\/f1000research.134171.2","relation":{"has-version":[{"id-type":"doi","id":"10.12688\/f1000research.134171.1","asserted-by":"subject"}],"has-review":[{"id-type":"doi","id":"10.5256\/f1000research.172135.r327102","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.172135.r327102","asserted-by":"object"}]},"ISSN":["2046-1402"],"issn-type":[{"value":"2046-1402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,26]]},"assertion":[{"value":"Indexed","URL":"https:\/\/f1000research.com\/articles\/12-604\/v2#article-reports","order":0,"name":"referee-status","label":"Referee status","group":{"name":"current-referee-status","label":"Current Referee Status"}},{"value":"10.5256\/f1000research.147203.r218626, Yongbin Wang, The First Affiliated Hospital, Xinxiang Medical University, Xinxiang, Henan Province, 24 Nov 2023, version 1, 1 approved, 1 not approved","URL":"https:\/\/f1000research.com\/articles\/12-604\/v1#referee-response-218626","order":0,"name":"referee-response-218626","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"<b>Hind Monadhel<\/b>; \n<i>Posted: 18 Sep 2024<\/i>; Dear Dr. Wang,  Thank you for your thoughtful and constructive feedback on our manuscript. We have carefully considered your comments and made the necessary revisions to improve the paper. We sincerely appreciate your insightful suggestions, which have significantly contributed to strengthening the manuscript","URL":"https:\/\/f1000research.com\/articles\/12-604\/v2#referee-comment-12473","order":1,"name":"referee-comment-12473","label":"Referee Comment","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.5256\/f1000research.172135.r327102, Bekir Kocazeybek, Istanbul University\u2014Cerrahpasa, Istanbul, 06 Nov 2024, version 2, indexed","URL":"https:\/\/f1000research.com\/articles\/12-604\/v2#referee-response-327102","order":2,"name":"referee-response-327102","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"The author(s) declared that no grants were involved in supporting this work","order":3,"name":"grant-information","label":"Grant Information"},{"value":"This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.","order":0,"name":"copyright-info","label":"Copyright"}]}}